Sinofn Health
Sinofn Health
In the modern era of health and wellness, the global supply chain has shifted from simple commodity procurement to strategic technology partnerships. As an international vitamin corporation, SINOFN Health understands that successful product deployment requires more than manufacturing—it requires scientific validation, localized regulatory compliance, and a future-proof technology roadmap.
The global nutraceutical market is transitioning towards "Bio-Precision." Consumers no longer seek generic multivitamins; they demand evidence-based, condition-specific solutions. From the integration of GABA for sleep architecture to Cyclic Adenosine Monophosphate (cAMP) for metabolic health, the current industrial landscape mandates that suppliers act as Contract Research & Manufacturing Organizations (CRMO) rather than mere factories.
Operating across borders requires an intricate understanding of regional regulatory landscapes, including FDA (USA), EFSA (Europe), and NMPA (China) standards. SINOFN provides the bridge, offering:
Founded in 2012, SINOFN Health was born from a clinical necessity. Witnessing the struggles of families with PKU (Phenylketonuria), Mrs. Liu established a mission-driven entity. Today, this mission has expanded into a global network that combines profitability with high-impact public health initiatives.
R&D Backbone: Our partnership with the Chinese Academy of Sciences ensures our "Information Gain" is superior. We aren't just manufacturers; we are innovators. Our R&D center in Tianjin is a hub for bioavailability optimization and formulation science.
Dr. Tan Shengjie (Peking University): 15+ years in metabolic disorder formulations.
Dr. Zhang Ying (CAS): Specialist in bioactive compound delivery systems.
Hans van Dijk (Netherlands): EU regulatory expert and lead process engineer.
Our industrial roadmap is focused on the next generation of nutraceuticals. We are actively investing in:
Our facility is not just a plant; it is a validated GMP-compliant ecosystem. With 10+ dedicated lines for softgels, gummies, and powders, we provide the scale to match the ambitions of global brands.
A: We operate with ISO 22000, HACCP, and FSSC 22000 certifications. Our regulatory team performs a gap analysis on your target market’s requirements (e.g., EU food safety laws or US FDA GRAS status) before we initiate the production process, ensuring zero friction at the border.
A: Absolutely. Our R&D center is specifically designed for agility. We provide pilot-scale runs (small batch) to validate your product formula before committing to mass manufacturing, drastically reducing your Time-to-Market (TTM).
A: Our affiliation with the Chinese Academy of Sciences (CAS) grants us access to cutting-edge biochemical research. This allows us to provide "Information Gain" to our clients—we provide not just the manufacturing service, but the underlying science that makes your product more effective than competitors.
